menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

New Cancer Vaccines Are on the Horizon. Disinformation Could Blunt Their Impact.

20 0
14.09.2026

Truthout is an indispensable resource for activists, movement leaders and workers everywhere. Please make this work possible with a quick donation.

Nearly five years ago, Chase Johnson was cured of breast cancer — but not of the profound anxiety that it would return.

When Johnson was originally diagnosed in 2021, the resident of Cary, North Carolina, was only 31 — nearly a decade away from the age at which regular mammograms are recommended — and she had no history of breast cancer in her family. She only got screened because her dog, Cato, kept poking her chest with his nose, which helped her discover a lump.

Doctors discovered that Johnson had stage 2B triple-negative breast cancer, a rare and aggressive form. They treated her with chemotherapy, radiation, and surgery, and in 2022, they declared her cancer free. Her oncologist warned her, however, that there was a 40% chance the cancer would return.

Anxious about that prospect, Johnson enrolled in a clinical trial at the Cleveland Clinic testing a new breast cancer vaccine, developed in partnership with Anixa Biosciences. That vaccine has shown positive early results: In nearly three-quarters of the participants, including Johnson, it has generated an immune response.

“It’s just so promising and as a patient, it gave me a lot of hope,” said Johnson, now 37. “I feel much more protected having done it.”

New HHS Panel Appointee Pushed Unfounded Theory Linking COVID Shots to Cancer

In the past two decades, there has been steady progress in developing vaccines for cancer. The vaccine Johnson is taking isn’t one of them, but researchers are especially excited about the potential of mRNA vaccines, which use synthetic genetic instructions to teach a person’s immune system how to recognize and destroy unique proteins found on cancer cells.

Just last month, pharmaceutical companies Moderna and Merck announced that a personalized mRNA cancer vaccine, combined with an immunotherapy drug, had succeeded in a late-stage trial for skin cancer. The news raised hopes that a wave of new cancer vaccines could be just over the horizon.

But will Americans be willing to take them?

Many doctors and researchers are concerned that vaccine misinformation — amplified by the Trump administration — and the resulting increase in vaccine hesitancy could blunt the impact of the new vaccines. In particular, they cite the false claim, which originated with mRNA COVID vaccines, that mRNA vaccines can super-charge tumors, creating so-called turbo cancer.

Many point to the human papillomavirus (HPV) vaccine as a cautionary tale.

Some strains of HPV, which is spread through sexual contact, can cause cancer of the cervix, vagina, vulva, penis, anus, mouth, throat, head or neck. In........

© Truthout